Abbott ABT Nutritional Products — R&D
Other segment segments
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Abbott's nutritional products — r&d.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Abbott's nutritional products — R&D?
- Abbott (ABT) reported nutritional products — R&D of $54M in Q1 2026.
- How has Abbott's nutritional products — R&D changed year-over-year?
- Abbott's nutritional products — R&D increased by 3.8% year-over-year, from $52M to $54M.
- What is the long-term trend for Abbott's nutritional products — R&D?
- Over 3 years (2022 to 2025), Abbott's nutritional products — R&D has grown at a 3.7% compound annual growth rate (CAGR), from $191M to $213M.
- What does nutritional products — R&D mean?
- Spending on innovation and development for new nutritional products.
- How do you interpret nutritional products — R&D?
- Higher spending reflects a commitment to long-term innovation, whereas a significant decline might suggest a shift in strategy or cost-cutting measures.
- How does nutritional products — R&D compare across companies?
- Standard R&D expense metric for life sciences and consumer health companies.